Biocon buys Vizag API plant from supplier Acacia
Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.
Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.
Siegfried Holdings has completed the takeover of BASF CEO Kurt Brock called the firm’s “relatively successful” pharma business.
UPDATE
The MHRA has signed a Memorandum of Understanding (MOU) with Indian regulators to help ensure the quality of drugs in the UK.
Got experience in endocrinology and metabolism indications R&D? Chiltern has added a new offering and says it is looking to hire.
BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.